Johnson & Johnson (China) Investment Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Subsidiary
- Established
- 1998-05-21
- Employees
- -
- Market Cap
- -
- Website
- http://www.jnj.com.cn
Clinical Trials
2
Active:0
Completed:2
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Johnson & Johnson (China) Investment Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT04312659
- Locations
- 🇨🇳
The Childrens Hospital Zhejiang University School Of Medicine, Hangzhou, China
🇨🇳Ruijin Hospital Shanghai Jiao Tong University, Shanghai, China
🇨🇳Guangzhou Women And Children's Medical Center, Guangzhou, China
A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery
Completed
- Conditions
- Lung NeoplasmsPulmonary Disease, Chronic Obstructive
- First Posted Date
- 2020-03-18
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- Johnson & Johnson (China) Investment Ltd.
- Target Recruit Count
- 290
- Registration Number
- NCT04313361
- Locations
- 🇨🇳
Xuanwu Hospital ,Capital Medical University, Beijing, China
🇨🇳Ruijin Hospital Shanghai Jiao Tong University, Shanghai, China
🇨🇳The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
News
No news found